Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Scholten WJ"'
Autor:
Reuvekamp T; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC location Universiteit van Amsterdam, Amsterdam, The Netherlands., Janssen LLG; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Ngai LL; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Carbaat-Ham J; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., den Hartog D; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Scholten WJ; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Kelder A; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Hanekamp D; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.; Department of Hematology, Erasmus MC Cancer Institute and University Medical Center Rotterdam, Rotterdam, The Netherlands., Wensink E; Department of Radiology and Nuclear Medicine, Amsterdam UMC location Universiteit van Amsterdam, Amsterdam, The Netherlands., van Gils N; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Gradowska P; Department of Hematology, Erasmus MC Cancer Institute and University Medical Center Rotterdam, Rotterdam, The Netherlands.; HOVON Foundation, Rotterdam, The Netherlands., Löwenberg B; Department of Hematology, Erasmus MC Cancer Institute and University Medical Center Rotterdam, Rotterdam, The Netherlands., Ossenkoppele GJ; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., van de Loosdrecht AA; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Westers TM; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Smit L; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Bachas C; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Cloos J; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2024 Aug 23. Date of Electronic Publication: 2024 Aug 23.
Autor:
Tettero JM; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Heidinga ME; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Mocking TR; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Fransen G; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Kelder A; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Scholten WJ; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Snel AN; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Ngai LL; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Bachas C; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., van de Loosdrecht AA; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Ossenkoppele GJ; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., de Leeuw DC; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Cloos J; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands. j.cloos@amsterdamumc.nl.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands. j.cloos@amsterdamumc.nl., Janssen JJWM; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
Leukemia [Leukemia] 2024 Mar; Vol. 38 (3), pp. 630-639. Date of Electronic Publication: 2024 Jan 25.
Autor:
Ngai LL; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Hanekamp D; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.; Department of Hematology, Erasmus MC, Rotterdam, Netherlands., Janssen F; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Carbaat-Ham J; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Hofland MAMA; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Fayed MMHE; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Kelder A; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Oudshoorn-van Marsbergen L; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Scholten WJ; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Snel AN; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Bachas C; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Tettero JM; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Breems DA; Department of Hematology, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium., Fischer T; Department of Hematology and Oncology, Otto von Guericke University Hospital Magdeburg, Magdeburg, Germany., Gjertsen BT; Department of Clinical Science, Haukeland University Hospital, Bergen, Norway., Griškevičius L; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos and Vilnius University, Vilnius, Lithuania., Juliusson G; Department of Hematology, Skanes University Hospital, Lund, Sweden., van de Loosdrecht AA; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Maertens JA; Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium., Manz MG; Department of Medical Oncology and Hematology, University Hospital, Zurich, Switzerland.; Swiss Group for Clinical Cancer Research, Bern, Switzerland., Pabst T; Swiss Group for Clinical Cancer Research, Bern, Switzerland.; Department of Medical Oncology, Inselspital, University Hospital, Bern, Switzerland., Passweg JR; Swiss Group for Clinical Cancer Research, Bern, Switzerland.; Department of Hematology, University Hospital, Basel, Switzerland., Porkka K; Department of Hematology, Helsinki University Hospital Cancer Center, Helsinki, Finland., Valk PJM; Department of Hematology, Erasmus MC, Rotterdam, Netherlands., Gradowska P; Dutch-Belgian Hemato-Oncology Cooperative Group Data Center-Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Löwenberg B; Department of Hematology, Erasmus MC, Rotterdam, Netherlands., de Leeuw DC; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Janssen JJWM; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Ossenkoppele GJ; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Cloos J; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Publikováno v:
Blood [Blood] 2023 May 25; Vol. 141 (21), pp. 2657-2661.
Autor:
Hanekamp D; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Snel AN; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Kelder A; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Scholten WJ; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Khan N; Institute of Immunology and Immunotherapy, Department of Clinical Immunology, University of Birmingham, Birmingham, United Kingdom., Metzner M; Medical Research Council Molecular Hematology Unit, Oxford Centre for Hematology, Oxford BRC, University of Oxford and Oxford University Hospitals National Health Service Trust, Oxford, United Kingdom., Irno-Consalvo M; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Sugita M; Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA., de Jong A; Dutch Childhood Oncology Group, Utrecht, the Netherlands., Oude Alink S; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Eidhof H; Department of Clinical Chemistry, Medisch Spectrum Twente/Medlon, Enschede, the Netherlands., Wilhelm M; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany., Feuring-Buske M; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany., Slomp J; Department of Clinical Chemistry, Medisch Spectrum Twente/Medlon, Enschede, the Netherlands., van der Velden VHJ; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Sonneveld E; Dutch Childhood Oncology Group, Utrecht, the Netherlands., Guzman M; Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Roboz GJ; Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Buccisano F; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Vyas P; Medical Research Council Molecular Hematology Unit, Oxford Centre for Hematology, Oxford BRC, University of Oxford and Oxford University Hospitals National Health Service Trust, Oxford, United Kingdom., Freeman S; Institute of Immunology and Immunotherapy, Department of Clinical Immunology, University of Birmingham, Birmingham, United Kingdom., Bachas C; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Ossenkoppele GJ; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Schuurhuis GJ; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Cloos J; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Publikováno v:
British journal of haematology [Br J Haematol] 2020 Sep; Vol. 190 (6), pp. 891-900. Date of Electronic Publication: 2020 Apr 02.
Autor:
Zeijlemaker W; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Grob T; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., Meijer R; Clinical trial Center- HOVON data center, Erasmus University Medical Center, Rotterdam, The Netherlands., Hanekamp D; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Kelder A; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Carbaat-Ham JC; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Oussoren-Brockhoff YJM; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Snel AN; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Veldhuizen D; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Scholten WJ; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Maertens J; Department of Hematology, University Hospitals Leuven, Campus Gasthuisberg, Leuven, Belgium., Breems DA; Department of Hematology, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium., Pabst T; Department of Hematology, Inselspital, Bern University Hospital, Bern, Switzerland., Manz MG; Department of Hematology, University and University Hospital Zürich, Zürich, Switzerland., van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Slomp J; Department of Clinical Chemistry, Medisch Spectrum Twente/Medlon, Enschede, The Netherlands., Preijers F; Department of Laboratory Medicine - Laboratory for Hematology, Radboud University Nijmegen Medical Center, RUNMC, Nijmegen, The Netherlands., Cloos J; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands., van de Loosdrecht AA; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Löwenberg B; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., Valk PJM; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., Jongen-Lavrencic M; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., Ossenkoppele GJ; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Schuurhuis GJ; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands. gj.schuurhuis@vumc.nl.
Publikováno v:
Leukemia [Leukemia] 2019 May; Vol. 33 (5), pp. 1102-1112. Date of Electronic Publication: 2018 Dec 12.
Autor:
Cloos J; Department of Hematology, VU University Medical Center; Pediatric Oncology/Hematology, VU University Medical Center; j.cloos@vumc.nl., Harris JR; Janssen Research & Development, LLC., Janssen JJWM; Department of Hematology, VU University Medical Center., Kelder A; Department of Hematology, VU University Medical Center., Huang F; Janssen Research & Development, LLC., Sijm G; Department of Hematology, VU University Medical Center., Vonk M; Department of Hematology, VU University Medical Center., Snel AN; Department of Hematology, VU University Medical Center., Scheick JR; Department of Hematology, VU University Medical Center., Scholten WJ; Department of Hematology, VU University Medical Center., Carbaat-Ham J; Department of Hematology, VU University Medical Center., Veldhuizen D; Department of Hematology, VU University Medical Center., Hanekamp D; Department of Hematology, VU University Medical Center., Oussoren-Brockhoff YJM; Department of Hematology, VU University Medical Center., Kaspers GJL; Pediatric Oncology/Hematology, VU University Medical Center; Princess Máxima Center for Pediatric Oncology., Schuurhuis GJ; Department of Hematology, VU University Medical Center., Sasser AK; Janssen Research & Development, LLC., Ossenkoppele G; Department of Hematology, VU University Medical Center.
Publikováno v:
Journal of visualized experiments : JoVE [J Vis Exp] 2018 Mar 05 (133). Date of Electronic Publication: 2018 Mar 05.
Autor:
Zeijlemaker W; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Kelder A; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Oussoren-Brockhoff YJ; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Scholten WJ; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Snel AN; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Veldhuizen D; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Cloos J; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands., Ossenkoppele GJ; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Schuurhuis GJ; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Leukemia [Leukemia] 2016 Mar; Vol. 30 (3), pp. 708-15. Date of Electronic Publication: 2015 Sep 16.
Autor:
Zeijlemaker W; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Kelder A; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Oussoren-Brockhoff YJ; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Scholten WJ; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Snel AN; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Veldhuizen D; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Cloos J; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands., Ossenkoppele GJ; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Schuurhuis GJ; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Leukemia [Leukemia] 2016 Feb; Vol. 30 (2), pp. 439-46. Date of Electronic Publication: 2015 Sep 16.
Autor:
Terwijn M; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Zeijlemaker W; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Kelder A; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Rutten AP; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Snel AN; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Scholten WJ; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Pabst T; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Verhoef G; Department of Hematology, University Hospital Leuven, Leuven, Belgium., Löwenberg B; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., Zweegman S; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Ossenkoppele GJ; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Schuurhuis GJ; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
Publikováno v:
PloS one [PLoS One] 2014 Sep 22; Vol. 9 (9), pp. e107587. Date of Electronic Publication: 2014 Sep 22 (Print Publication: 2014).
Autor:
Terwijn M; Monique Terwijn, Angèle Kelder, Peter C. Huijgens, Angelika M. Dräger, Yvonne J.M. Oussoren, Willemijn J. Scholten, Alexander N. Snel, Gert J. Ossenkoppele, and Gerrit J. Schuurhuis, VU University Medical Centre; Bart J. Biemond, Academic Medical Centre, Amsterdam; Wim L.J. van Putten, Vincent H.J. van der Velden, Georgine E. de Greef, Peter J.M. Valk, Mojca Jongen-Lavrecic, and Bob Löwenberg, Erasmus University Medical Centre; Rik A. Brooimans, Jan W. Gratama, Erasmus University Medical Centre/Daniel den Hoed Cancer Centre, Rotterdam; Frank W.M.B. Preijers, Radboud University Nijmegen Medical Center, Nijmegen; Michel van Gelder, University Medical Centre, Maastricht; Pierre Wijermans, Haga Hospital, The Hague; Marie-Cecile Legdeur and Jennita Slomp, Medisch Spectrum Twente, Enschede; Jurgen Kuball, University Medical Center Utrecht; Okke de Weerdt, St. Antonius Hospital, Nieuwegein; Leo F. Verdonck, Isala Clinics, Zwolle, the Netherlands; Thomas Pabst, Bern University Hospital, Bern; Urs Schanz, University Hospital, Zürich; Jakob R. Passweg, Basel University Hospital, Basel; Mario Bargetzi, Kantonspital, Aarau; Yves Chalandon, University Hospital of Geneva, Geneva; Urs Hess, Kantonsspital, St. Gallen, Switzerland; Johan Maertens, University Hospital Gasthuisberg; Nancy Boeckx, University Hospitals Leuven and Katholieke Universiteit Leuven, Leuven; Carlos Graux, Cliniques Universitaires-Université Catholique de Louvain, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, St. Luc Hospital, Brussels, Belgium., van Putten WL, Kelder A, van der Velden VH, Brooimans RA, Pabst T, Maertens J, Boeckx N, de Greef GE, Valk PJ, Preijers FW, Huijgens PC, Dräger AM, Schanz U, Jongen-Lavrecic M, Biemond BJ, Passweg JR, van Gelder M, Wijermans P, Graux C, Bargetzi M, Legdeur MC, Kuball J, de Weerdt O, Chalandon Y, Hess U, Verdonck LF, Gratama JW, Oussoren YJ, Scholten WJ, Slomp J, Snel AN, Vekemans MC, Löwenberg B, Ossenkoppele GJ, Schuurhuis GJ
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2013 Nov 01; Vol. 31 (31), pp. 3889-97. Date of Electronic Publication: 2013 Sep 23.